Literature DB >> 20206684

Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2.

Verena Boschert1, Anja Krippner-Heidenreich, Marcus Branschädel, Jessica Tepperink, Andrew Aird, Peter Scheurich.   

Abstract

Most members of the tumor necrosis factor ligand family form noncovalently linked homotrimers, capable to bind up to three molecules of the respective membrane receptors. For several receptors a membrane distal homophilic interaction domain has been identified, called pre-ligand binding assembly domain. Accordingly, affinity values determined by typical equilibrium binding studies are likely to be influenced by avidity effects. Using our recently introduced covalently stabilized TNF (single chain TNF, scTNF), we have here investigated receptor-ligand binding stoichiometry in our well characterized system of TNFR-Fas chimeras. We produced scTNF derivatives with functionally deleted individual receptor binding sites, resulting in TNF mutants capable to only bind to one or two receptor molecules, rather than three. Equilibrium binding affinity studies on ice with these molecules revealed no significant changes after a single receptor binding site had been functionally deleted. In contrast, functional abrogation of two receptor binding sites showed a strong decrease in both, affinity and bioactivity on TNFR2-Fas. In contrast, TNFR1-Fas ligand binding and receptor activation was only affected after functional deletion of all three receptor binding sites. Our data demonstrate pivotal differences in ligand/receptor interactions between TNFR1-Fas and TNFR2-Fas, arguing for avidity effects important for TNF binding and downstream signaling of TNFR2, but to a lesser extent of TNFR1. These results are supported by data revealed from chemical crosslinking experiments suggesting the existence of preformed TNFR-Fas homodimers. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206684     DOI: 10.1016/j.cellsig.2010.02.011

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  15 in total

1.  The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand.

Authors:  Christine Richter; Sylvia Messerschmidt; Gerlinde Holeiter; Jessica Tepperink; Sylvia Osswald; Andrea Zappe; Marcus Branschädel; Verena Boschert; Derek A Mann; Peter Scheurich; Anja Krippner-Heidenreich
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

2.  Functional intersection of Human Defensin 5 with the TNF receptor pathway.

Authors:  Wuyuan Lu; Erik de Leeuw
Journal:  FEBS Lett       Date:  2014-03-26       Impact factor: 4.124

3.  Dominant negative effects of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 4 on TRAIL receptor 1 signaling by formation of heteromeric complexes.

Authors:  Simon Neumann; Jan Hasenauer; Nadine Pollak; Peter Scheurich
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

4.  Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members.

Authors:  Julia T Warren; Christopher A Nelson; Corinne E Decker; Wei Zou; Daved H Fremont; Steven L Teitelbaum
Journal:  Sci Signal       Date:  2014-08-19       Impact factor: 8.192

5.  Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function.

Authors:  Julia T Warren; Wei Zou; Corinne E Decker; Nidhi Rohatgi; Christopher A Nelson; Daved H Fremont; Steven L Teitelbaum
Journal:  J Cell Biochem       Date:  2015-11       Impact factor: 4.429

6.  ATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibody.

Authors:  Kirstin A Zettlitz; Verena Lorenz; Karlheinz Landauer; Sabine Münkel; Andreas Herrmann; Peter Scheurich; Klaus Pfizenmaier; Roland Kontermann
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

7.  A trimeric structural fusion of an antagonistic tumor necrosis factor-α mutant enhances molecular stability and enables facile modification.

Authors:  Masaki Inoue; Daisuke Ando; Haruhiko Kamada; Shintaro Taki; Mayumi Niiyama; Yohei Mukai; Takashi Tadokoro; Katsumi Maenaka; Taisuke Nakayama; Yuji Kado; Tsuyoshi Inoue; Yasuo Tsutsumi; Shin-Ichi Tsunoda
Journal:  J Biol Chem       Date:  2017-02-24       Impact factor: 5.157

8.  Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.

Authors:  Sonia Schuepbach-Mallepell; Dolon Das; Laure Willen; Michele Vigolo; Aubry Tardivel; Luc Lebon; Christine Kowalczyk-Quintas; Josquin Nys; Cristian Smulski; Timothy S Zheng; Klaus Maskos; Alfred Lammens; Xuliang Jiang; Henry Hess; Seng-Lai Tan; Pascal Schneider
Journal:  J Biol Chem       Date:  2015-05-07       Impact factor: 5.157

9.  Quantitative single-molecule localization microscopy combined with rule-based modeling reveals ligand-induced TNF-R1 reorganization toward higher-order oligomers.

Authors:  Franziska Fricke; Sebastian Malkusch; Gaby Wangorsch; Johannes F Greiner; Barbara Kaltschmidt; Christian Kaltschmidt; Darius Widera; Thomas Dandekar; Mike Heilemann
Journal:  Histochem Cell Biol       Date:  2014-02-12       Impact factor: 4.304

10.  Are different stoichiometries feasible for complexes between lymphotoxin-alpha and tumor necrosis factor receptor 1?

Authors:  Nahren Manuel Mascarenhas; Johannes Kästner
Journal:  BMC Struct Biol       Date:  2012-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.